Browsing by Subject "calcification"
Now showing items 1-2 of 2
-
(2022-03-15)Department: Biomedical EngineeringIn 2017 the sclerostin targeting monoclonal antibody Romosozumab was approved as a treatment for post-menopausal osteoporosis (PMO) despite cardiovascular side effects discovered in clinical trials. Previous studies indicated ...
-
(2018-04-11)Department: Biomedical EngineeringCalcific aortic valve disease affects a quarter of those over 65 in the US alone. The only treatment is aortic valve replacement, but this intervention carries with it a high rate of morbidity and mortality and is often a ...